Patents by Inventor Christine Baumgartner

Christine Baumgartner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7169612
    Abstract: Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: January 30, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Evi Kostenis, Paulus Wohlfart, Jochen Huber, Kai Rosport, Andreas Bueltmann, Christine Baumgartner, Götz Muench, Martin Ungerer
  • Publication number: 20040132182
    Abstract: Mammals and myocardial mammal cells transformed with G protein coupled receptor EDG2 are presented for use in an animal model for heart failure.
    Type: Application
    Filed: November 12, 2003
    Publication date: July 8, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Evi Kostenis, Paulus Wohlfart, Jochen Huber, Kai Rosport, Andreas Bueltmann, Christine Baumgartner, Gotz Muench, Martin Ungerer
  • Publication number: 20030049258
    Abstract: A method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle i by administering an agent capable of binding to a phosducin binding site of G&bgr;&ggr; is provided. Said phosducin binding site is preferably a binding site of N-terminal truncated phosducin. Further, methods of identifying compounds capable of increasing the contractility of a heart muscle and methods of identifying compounds capable of inhibiting G&bgr;&ggr;-mediated processes are provided.
    Type: Application
    Filed: September 11, 2001
    Publication date: March 13, 2003
    Inventors: Martin Ungerer, Gotz Munch, Christine Baumgartner, Kai Rosport, Karl-Ludwig Laugwitz, Martin Lohse
  • Patent number: 5466746
    Abstract: The aqueous emulsions based on(a) 100 parts by weight of organopolysiloxanes which contain polar groups on Si--C-bonded hydrocarbon radicals and(b) not more than 50 parts by weight of alkyl polyglycosides which are stable toward high concentrations of foreign electrolytes.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: November 14, 1995
    Assignee: Wacker-Chemie GmbH
    Inventors: Michael Geck, Bernward Deubzer, Christine Baumgartner, Hans-Jurgen Lautenschlager, Johann Sejpka